| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9675 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8030 |
| P-glycoprotein Substrate | Substrate | 0.6695 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7720 |
| Non-inhibitor | 0.8406 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7816 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5715 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8368 |
| CYP450 2D6 Substrate | Non-substrate | 0.8603 |
| CYP450 3A4 Substrate | Substrate | 0.7872 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8096 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8942 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8071 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8112 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6606 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7920 |
| Non-inhibitor | 0.6160 |
| AMES Toxicity | Non AMES toxic | 0.8807 |
| Carcinogens | Non-carcinogens | 0.8932 |
| Fish Toxicity | High FHMT | 0.9888 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9911 |
| Honey Bee Toxicity | High HBT | 0.8190 |
| Biodegradation | Not ready biodegradable | 0.9965 |
| Acute Oral Toxicity | III | 0.6075 |
| Carcinogenicity (Three-class) | Non-required | 0.5153 |